当前位置: 首页 >> 检索结果
共有 10930 条符合本次的查询结果, 用时 3.0652462 秒

81. Analysis of the Article "Intestinal Epithelial Serotonin as a Novel Target for Treating Disorders of Gut-Brain Interaction and Mood".

作者: Bin He.;Yilian Zhong.;Zhaochi Yue.;Jun Li.;Yaling Li.
来源: Gastroenterology. 2025年

82. Evaluating the Translational Potential of Gut-Restricted SERT Modulation.

作者: Jiaqi Wang.;Xiufeng Zhao.;Xuemin Jin.
来源: Gastroenterology. 2025年

83. Prevalence-based screening by anti-HCV reflex HCV antigen test and accessible post-screening care towards elimination of hepatitis C in rural villages.

作者: Kuan-Chen Pan.;Nien-Tzu Hsu.;Ying-Mei Tang.;Yu-Chen Lee.;Hsiu-Ling Kuo.;Tung-Jung Huang.;Chun-Mei Tseng.;Sheng-Nan Lu.;Te-Sheng Chang.
来源: BMC Gastroenterol. 2025年25卷1期400页
One major barrier to the goals of hepatitis C virus (HCV) elimination is identification and linkage-to-care for those with HCV infection. The aim of this research was to develop a strategy to help achieve HCV elimination in remote rural villages.

84. Aggregate index of systemic inflammation tied to increased fatty liver disease risk: insights from NHANES data.

作者: Meng Zhang.;Yuan Yuan.;Chenglong Wang.;You Huang.;Mingli Fan.;Xiangling Li.;Zujie Qin.
来源: BMC Gastroenterol. 2025年25卷1期399页
Fatty liver disease (FLD), characterized by hepatic lipid accumulation, impairs quality of life and can progress to cirrhosis and hepatocellular carcinoma, imposing a healthcare burden. This study investigates the association between the aggregate index of systemic inflammation (AISI) and FLD prevalence, evaluating AISI's potential as an early biomarker for risk assessment.

85. Correlation analyses of ultrasonographic and histopathological characteristics of porta hepatis lymph nodes in biliary atresia.

作者: Zhen Huang.;Wen Ling.;Guorong Lyu.;Shuxia Xu.;Fengying Ye.;Yifan Fang.;Zongjie Weng.;Qiumei Wu.
来源: BMC Gastroenterol. 2025年25卷1期398页
To perform correlation analyses between the ultrasonographic characteristics of porta hepatis lymph nodes (PHLNs) and the pathological features of PHLNs and the liver in biliary atresia (BA).

86. The effect of chewing gum on postoperative ileus after laparotomy for gastroduodenal perforations: a randomized controlled trial.

作者: Joshua Muhumuza.;Selamo F Molen.;Godefroy N Bassara.;Musa A Waziri.;Stephen M Kithinji.;Kiyaka M Sonye.;Mugisho M Leocadie.;ByaMungu P Kagenderezo.;Esperant T Tshimanga.;Tatana M Faustin.;Herman Lule.
来源: BMC Gastroenterol. 2025年25卷1期402页
Prolonged postoperative ileus is linked to a higher risk of additional complications, longer hospital stays, and higher healthcare expenses. There are few randomized controlled trials on the impact of chewing gum on the duration of ileus in patients undergoing emergency surgery, notably those with peritonitis. Compelling evidence from studies on elective procedures demonstrates that chewing gum can lessen the duration of ileus. This trial aimed to examine the effect of chewing gum on the length of the postoperative ileus which develop after laparotomy for gastroduodenal perforations.

87. The efficacy of retrograde and antegrade enemas in the management of low anterior resection syndrome in patients undergoing rectal resection: a systematic review and meta-analysis.

作者: Yuan Yuan.;Qi Gao.;Hui Yang.
来源: BMC Gastroenterol. 2025年25卷1期401页
Rectal resection could potentially cause low anterior resection syndrome (LARS). Although recent studies have reported the efficacy of enema against LARS, no systematic review and meta-analysis has been conducted.

88. Patient Involvement and Methodological Considerations in the UGIC Endoscopy Screening Cluster Trial.

作者: Zhen-Ya Chen.;Tian-Zeng Bian.;Zhou-Yun Zhao.;Yi-Qi Chen.;Wen-Tian Cao.
来源: Gastroenterology. 2025年

89. Reimagining HRME's Global Role: Operator Expertise Gap Undermines Cost-Effective ESCN Screening.

作者: Dianbao Zuo.;Kangkang Ji.
来源: Gastroenterology. 2025年

90. Gastric Cancer Prevention in the United States: A Work in Progress.

作者: Robert J Huang.;Paul Moayyedi.;Shailja C Shah.;Yanghee Woo.;Andrew Y Wang.;Joo Ha Hwang.
来源: Gastroenterology. 2025年

91. Evaluation of post-market adverse events of lubiprostone: a real-world adverse event analysis from the FAERS database.

作者: Qingqing Li.;Jijun Zhang.;Chuanli Yang.;Xiushan Dong.;Yan Wang.
来源: BMC Gastroenterol. 2025年25卷1期395页
Lubiprostone is a selective intestinal chloride channel activator approved for treating chronic idiopathic constipation and constipation-predominant irritable bowel syndrome in adults. However, real-world data on its long-term safety, particularly regarding adverse events necessitating ongoing supplementation, remain limited.

92. Challenges and needs in the management of non-alcoholic fatty liver disease from the perspective of gastroenterology and hepatology specialists: a qualitative study.

作者: Farzad Salmanizadeh.;Sakineh Sabzevari.;Sara Shafieipour.;Mohammad Javad Zahedi.;Afshin Sarafinejad.
来源: BMC Gastroenterol. 2025年25卷1期396页
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, and it poses a significant threat to public health. There is insufficient documented evidence about the problems and needs of patients and physicians in managing NAFLD. This study aimed to explore the challenges and needs in managing NAFLD from the perspective of gastroenterology and hepatology (GH) specialists.

93. Ascites complications risk factors of decompensated cirrhosis patients: logistic regression and prediction model.

作者: Xiaolong Zheng.;Wei Wei.
来源: BMC Gastroenterol. 2025年25卷1期397页
The study mainly aim at exploring the ascites risk factors among decompensated cirrhosis patients via constructing the prediction model of ascites incidence.

94. Reply.

作者: Mimi C Tan.;Rebecca R Richards-Kortum.;Sharmila Anandasabapathy.
来源: Gastroenterology. 2025年

95. Can HRME Be Widely Adopted for Esophageal Cancer Screening in Low-Resource Settings?

作者: He Yizi.;He Haiqing.;Xie Yongzhi.
来源: Gastroenterology. 2025年

97. Presentation of the Julius M. Friedenwald Medal to David Lieberman, MD, AGAF.

作者: Sarah J Diamond.;Brian Fennerty.;David A Katzka.
来源: Gastroenterology. 2025年169卷1期165-170.e8页

98. Association between proteinuria changes and colorectal cancer incidence: evidence from a nationwide cohort study.

作者: Soo Young Oh.;Kyung-Do Han.;Ga Yoon Ku.;Won-Kyung Kang.
来源: BMC Gastroenterol. 2025年25卷1期392页
The presence of excess proteins in the urine, known as proteinuria, has been linked to various health conditions, including chronic kidney disease and cancer. Emerging evidence suggests an association between proteinuria and colorectal cancer, a leading global cause of cancer-related morbidity and mortality. However, the impact of changes in proteinuria status on colorectal cancer risk remains unclear. Understanding this relationship may identify proteinuria as a modifiable risk factor for colorectal cancer prevention.

99. Association between circadian syndrome and MASLD risk: evidence from a large cross-sectional study.

作者: Jihan Sun.;Shuqi Mao.;Caide Lu.
来源: BMC Gastroenterol. 2025年25卷1期391页
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver condition closely associated with metabolic syndrome and linked to circadian disruptions. Circadian Syndrome (CircS), a constellation of metabolic and circadian dysregulations, has emerged as a risk factor for metabolic disorders. This study aims to examine the association between CircS and MASLD and to evaluate the potential relevance of CircS in identifying individuals at elevated MASLD risk.

100. Effect of chitosan nanoparticles conjugated with the cell free supernatant of Bifidobacterium bifidum on the expression of genes related to colorectal cancer in colon adenocarcinoma (Caco-2) cell line.

作者: Rahimeh Maqsoodi.;Masoumeh Saberpour.;Bita Bakhshi.;Fatemeh Fallah.
来源: BMC Gastroenterol. 2025年25卷1期394页
Colorectal cancer (CRC) is emerged as a global problem with high mortality rate; hence, finding of alternative treatment approaches is essential. The purposes of this research are to assess the impact of chitosan nanoparticles conjugated with the cell free supernatant of Bifidobacterium bifidum (CTNP/B.b-sup) on genes associated with CRC signaling pathways.
共有 10930 条符合本次的查询结果, 用时 3.0652462 秒